The medical device analytical testing outsourcing market valued for $4,744.84 million in 2021 and is estimated to reach $7,956.99 million by 2031, exhibiting a CAGR of 5.3% from 2022 to 2031.
Medical device analytical testing outsourcing refers to a specific type of contract between the manufacturer and the third-party companies for manufacturing, validation, packing, prototyping, designing, and verifying the medical devices in a sterile and controlled environment for supply chain management. In order to reduce business risks, accelerate product business expansion, and reduce costs, many medical device manufacturers companies go under outsource analytical testing activities. Electronics, finished products, and raw materials are the three main product categories in medical device outsourcing. The major factors driving the growth of global medical device analytical testing outsourcing market are rise in number of key players manufacturing medical devices and high adoption of analytical testing services for medical devices. In addition, rise in prevalence of chronic diseases has led to surge in the demand for new quality medical products, which also increases the adoption of outsourcing testing services. Conversely, the delay in medical devices approval due to lengthy procedure and time restrains the market growth. However, high growth potential in developing economies provide the lucrative opportunity to market growth.
The medical device analytical testing outsourcing market is segmented into service, end user, and region. By service, the market is categorized into physical testing, bioburden testing, sterility testing, and others. On the basis of end user, the market is segregated into medical device manufacturer and pharmaceutical companies. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global medical device analytical testing outsourcing market are Charles River Laboratories International, Inc., Element Materials Technology, Eurofins Scientific, Intetek Group plc, Pace Analytical, Medistri SA, North American Science Associates, LLC, SGS SA, The Smithers Group Inc., and WuXi AppTec.
Medical device analytical testing outsourcing refers to a specific type of contract between the manufacturer and the third-party companies for manufacturing, validation, packing, prototyping, designing, and verifying the medical devices in a sterile and controlled environment for supply chain management. In order to reduce business risks, accelerate product business expansion, and reduce costs, many medical device manufacturers companies go under outsource analytical testing activities. Electronics, finished products, and raw materials are the three main product categories in medical device outsourcing. The major factors driving the growth of global medical device analytical testing outsourcing market are rise in number of key players manufacturing medical devices and high adoption of analytical testing services for medical devices. In addition, rise in prevalence of chronic diseases has led to surge in the demand for new quality medical products, which also increases the adoption of outsourcing testing services. Conversely, the delay in medical devices approval due to lengthy procedure and time restrains the market growth. However, high growth potential in developing economies provide the lucrative opportunity to market growth.
The medical device analytical testing outsourcing market is segmented into service, end user, and region. By service, the market is categorized into physical testing, bioburden testing, sterility testing, and others. On the basis of end user, the market is segregated into medical device manufacturer and pharmaceutical companies. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global medical device analytical testing outsourcing market are Charles River Laboratories International, Inc., Element Materials Technology, Eurofins Scientific, Intetek Group plc, Pace Analytical, Medistri SA, North American Science Associates, LLC, SGS SA, The Smithers Group Inc., and WuXi AppTec.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical device analytical testing outsourcing market analysis from 2021 to 2031 to identify the prevailing medical device analytical testing outsourcing market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the medical device analytical testing outsourcing market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global medical device analytical testing outsourcing market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Service
- Physical Testing
- Bioburden Testing
- Sterility Testing
- Others
By End User
- Medical Device Manufacturer
- Pharmaceutical Companies
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- SGS SA
- Medistri SA
- Element Materials Technology
- Pace Analytical
- North American Science Associates, LLC
- The Smithers Group Inc.
- Eurofins Scientific
- Intetek Group plc
- WuXi AppTec
- Charles River Laboratories International, Inc.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Growing need for medical testing and validation
3.4.1.2. Rise in prevalence of cardiovascular diseases
3.4.1.3. Rise in technological advancements
3.4.2. Restraints
3.4.2.1. Delayed approval of medical devices
3.4.3. Opportunities
3.4.3.1. High growth potential in developing economies
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICE
4.1 Overview
4.1.1 Market size and forecast
4.2. Physical Testing
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3. Bioburden Testing
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.4. Sterility Testing
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country
4.5. Others
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market share analysis by country
CHAPTER 5: MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER
5.1 Overview
5.1.1 Market size and forecast
5.2. Medical Device Manufacturer
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3. Pharmaceutical Companies
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Service
6.2.3 North America Market size and forecast, by End User
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Key market trends, growth factors and opportunities
6.2.4.1.2 Market size and forecast, by Service
6.2.4.1.3 Market size and forecast, by End User
6.2.4.2 Canada
6.2.4.2.1 Key market trends, growth factors and opportunities
6.2.4.2.2 Market size and forecast, by Service
6.2.4.2.3 Market size and forecast, by End User
6.2.4.3 Mexico
6.2.4.3.1 Key market trends, growth factors and opportunities
6.2.4.3.2 Market size and forecast, by Service
6.2.4.3.3 Market size and forecast, by End User
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Service
6.3.3 Europe Market size and forecast, by End User
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Key market trends, growth factors and opportunities
6.3.4.1.2 Market size and forecast, by Service
6.3.4.1.3 Market size and forecast, by End User
6.3.4.2 France
6.3.4.2.1 Key market trends, growth factors and opportunities
6.3.4.2.2 Market size and forecast, by Service
6.3.4.2.3 Market size and forecast, by End User
6.3.4.3 UK
6.3.4.3.1 Key market trends, growth factors and opportunities
6.3.4.3.2 Market size and forecast, by Service
6.3.4.3.3 Market size and forecast, by End User
6.3.4.4 Italy
6.3.4.4.1 Key market trends, growth factors and opportunities
6.3.4.4.2 Market size and forecast, by Service
6.3.4.4.3 Market size and forecast, by End User
6.3.4.5 Spain
6.3.4.5.1 Key market trends, growth factors and opportunities
6.3.4.5.2 Market size and forecast, by Service
6.3.4.5.3 Market size and forecast, by End User
6.3.4.6 Rest of Europe
6.3.4.6.1 Key market trends, growth factors and opportunities
6.3.4.6.2 Market size and forecast, by Service
6.3.4.6.3 Market size and forecast, by End User
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Service
6.4.3 Asia-Pacific Market size and forecast, by End User
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 Japan
6.4.4.1.1 Key market trends, growth factors and opportunities
6.4.4.1.2 Market size and forecast, by Service
6.4.4.1.3 Market size and forecast, by End User
6.4.4.2 China
6.4.4.2.1 Key market trends, growth factors and opportunities
6.4.4.2.2 Market size and forecast, by Service
6.4.4.2.3 Market size and forecast, by End User
6.4.4.3 Australia
6.4.4.3.1 Key market trends, growth factors and opportunities
6.4.4.3.2 Market size and forecast, by Service
6.4.4.3.3 Market size and forecast, by End User
6.4.4.4 India
6.4.4.4.1 Key market trends, growth factors and opportunities
6.4.4.4.2 Market size and forecast, by Service
6.4.4.4.3 Market size and forecast, by End User
6.4.4.5 South Korea
6.4.4.5.1 Key market trends, growth factors and opportunities
6.4.4.5.2 Market size and forecast, by Service
6.4.4.5.3 Market size and forecast, by End User
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Key market trends, growth factors and opportunities
6.4.4.6.2 Market size and forecast, by Service
6.4.4.6.3 Market size and forecast, by End User
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Service
6.5.3 LAMEA Market size and forecast, by End User
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Key market trends, growth factors and opportunities
6.5.4.1.2 Market size and forecast, by Service
6.5.4.1.3 Market size and forecast, by End User
6.5.4.2 Saudi Arabia
6.5.4.2.1 Key market trends, growth factors and opportunities
6.5.4.2.2 Market size and forecast, by Service
6.5.4.2.3 Market size and forecast, by End User
6.5.4.3 South Africa
6.5.4.3.1 Key market trends, growth factors and opportunities
6.5.4.3.2 Market size and forecast, by Service
6.5.4.3.3 Market size and forecast, by End User
6.5.4.4 Rest of LAMEA
6.5.4.4.1 Key market trends, growth factors and opportunities
6.5.4.4.2 Market size and forecast, by Service
6.5.4.4.3 Market size and forecast, by End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021
CHAPTER 8: COMPANY PROFILES
8.1 SGS SA
8.1.1 Company overview
8.1.2 Key Executives
8.1.3 Company snapshot
8.1.4 Operating business segments
8.1.5 Product portfolio
8.1.6 Business performance
8.1.7 Key strategic moves and developments
8.2 Medistri SA
8.2.1 Company overview
8.2.2 Key Executives
8.2.3 Company snapshot
8.2.4 Operating business segments
8.2.5 Product portfolio
8.2.6 Business performance
8.2.7 Key strategic moves and developments
8.3 Element Materials Technology
8.3.1 Company overview
8.3.2 Key Executives
8.3.3 Company snapshot
8.3.4 Operating business segments
8.3.5 Product portfolio
8.3.6 Business performance
8.3.7 Key strategic moves and developments
8.4 Pace Analytical
8.4.1 Company overview
8.4.2 Key Executives
8.4.3 Company snapshot
8.4.4 Operating business segments
8.4.5 Product portfolio
8.4.6 Business performance
8.4.7 Key strategic moves and developments
8.5 North American Science Associates, LLC
8.5.1 Company overview
8.5.2 Key Executives
8.5.3 Company snapshot
8.5.4 Operating business segments
8.5.5 Product portfolio
8.5.6 Business performance
8.5.7 Key strategic moves and developments
8.6 The Smithers Group Inc.
8.6.1 Company overview
8.6.2 Key Executives
8.6.3 Company snapshot
8.6.4 Operating business segments
8.6.5 Product portfolio
8.6.6 Business performance
8.6.7 Key strategic moves and developments
8.7 Eurofins Scientific
8.7.1 Company overview
8.7.2 Key Executives
8.7.3 Company snapshot
8.7.4 Operating business segments
8.7.5 Product portfolio
8.7.6 Business performance
8.7.7 Key strategic moves and developments
8.8 Intetek Group plc
8.8.1 Company overview
8.8.2 Key Executives
8.8.3 Company snapshot
8.8.4 Operating business segments
8.8.5 Product portfolio
8.8.6 Business performance
8.8.7 Key strategic moves and developments
8.9 WuXi AppTec
8.9.1 Company overview
8.9.2 Key Executives
8.9.3 Company snapshot
8.9.4 Operating business segments
8.9.5 Product portfolio
8.9.6 Business performance
8.9.7 Key strategic moves and developments
8.10 Charles River Laboratories International, Inc.
8.10.1 Company overview
8.10.2 Key Executives
8.10.3 Company snapshot
8.10.4 Operating business segments
8.10.5 Product portfolio
8.10.6 Business performance
8.10.7 Key strategic moves and developments
List of Tables
Table 1. Global Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 2. Medical Device Analytical Testing Outsourcing Market for Physical Testing, by Region, 2021-2031 (Revenue, $Million)
Table 3. Medical Device Analytical Testing Outsourcing Market for Bioburden Testing, by Region, 2021-2031 (Revenue, $Million)
Table 4. Medical Device Analytical Testing Outsourcing Market for Sterility Testing, by Region, 2021-2031 (Revenue, $Million)
Table 5. Medical Device Analytical Testing Outsourcing Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 6. Global Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 7. Medical Device Analytical Testing Outsourcing Market for Medical Device Manufacturer, by Region, 2021-2031 (Revenue, $Million)
Table 8. Medical Device Analytical Testing Outsourcing Market for Pharmaceutical Companies, by Region, 2021-2031 (Revenue, $Million)
Table 9. Medical Device Analytical Testing Outsourcing Market, by Region, 2021-2031 (Revenue, $Million)
Table 10. North America Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 11. North America Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 12. North America Medical Device Analytical Testing Outsourcing Market, by Country, 2021-2031 (Revenue, $Million)
Table 13. U.S. Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 14. U.S. Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 15. Canada Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 16. Canada Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 17. Mexico Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 18. Mexico Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 19. Europe Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 20. Europe Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 21. Europe Medical Device Analytical Testing Outsourcing Market, by Country, 2021-2031 (Revenue, $Million)
Table 22. Germany Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 23. Germany Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 24. France Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 25. France Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 26. UK Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 27. UK Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 28. Italy Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 29. Italy Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 30. Spain Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 31. Spain Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 32. Rest of Europe Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 33. Rest of Europe Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 34. Asia-Pacific Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 35. Asia-Pacific Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 36. Asia-Pacific Medical Device Analytical Testing Outsourcing Market, by Country, 2021-2031 (Revenue, $Million)
Table 37. Japan Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 38. Japan Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 39. China Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 40. China Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 41. Australia Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 42. Australia Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 43. India Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 44. India Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 45. South Korea Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 46. South Korea Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 47. Rest of Asia-Pacific Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 48. Rest of Asia-Pacific Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 49. LAMEA Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 50. LAMEA Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 51. LAMEA Medical Device Analytical Testing Outsourcing Market, by Country, 2021-2031 (Revenue, $Million)
Table 52. Brazil Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 53. Brazil Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 54. Saudi Arabia Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 55. Saudi Arabia Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 56. South Africa Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 57. South Africa Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 58. Rest of LAMEA Medical Device Analytical Testing Outsourcing Market, by Service, 2021-2031 (Revenue, $Million)
Table 59. Rest of LAMEA Medical Device Analytical Testing Outsourcing Market, by End-user, 2021-2031 (Revenue, $Million)
Table 60. Sgs Sa: Key Executives
Table 61. Sgs Sa: Company Snapshot
Table 62. Sgs Sa: Operating Segments
Table 63. Sgs Sa: Product Portfolio
Table 64. Sgs Sa: Net Sales
Table 65. Sgs Sa: Key Stratergies
Table 66. Medistri Sa: Key Executives
Table 67. Medistri Sa: Company Snapshot
Table 68. Medistri Sa: Operating Segments
Table 69. Medistri Sa: Product Portfolio
Table 70. Medistri Sa: Net Sales
Table 71. Medistri Sa: Key Stratergies
Table 72. Element Materials Technology: Key Executives
Table 73. Element Materials Technology: Company Snapshot
Table 74. Element Materials Technology: Operating Segments
Table 75. Element Materials Technology: Product Portfolio
Table 76. Element Materials Technology: Net Sales
Table 77. Element Materials Technology: Key Stratergies
Table 78. Pace Analytical: Key Executives
Table 79. Pace Analytical: Company Snapshot
Table 80. Pace Analytical: Operating Segments
Table 81. Pace Analytical: Product Portfolio
Table 82. Pace Analytical: Net Sales
Table 83. Pace Analytical: Key Stratergies
Table 84. North American Science Associates, LLC: Key Executives
Table 85. North American Science Associates, LLC: Company Snapshot
Table 86. North American Science Associates, LLC: Operating Segments
Table 87. North American Science Associates, LLC: Product Portfolio
Table 88. North American Science Associates, LLC: Net Sales
Table 89. North American Science Associates, LLC: Key Stratergies
Table 90. The Smithers Group Inc.: Key Executives
Table 91. The Smithers Group Inc.: Company Snapshot
Table 92. The Smithers Group Inc.: Operating Segments
Table 93. The Smithers Group Inc.: Product Portfolio
Table 94. The Smithers Group Inc.: Net Sales
Table 95. The Smithers Group Inc.: Key Stratergies
Table 96. Eurofins Scientific: Key Executives
Table 97. Eurofins Scientific: Company Snapshot
Table 98. Eurofins Scientific: Operating Segments
Table 99. Eurofins Scientific: Product Portfolio
Table 100. Eurofins Scientific: Net Sales
Table 101. Eurofins Scientific: Key Stratergies
Table 102. Intetek Group plc: Key Executives
Table 103. Intetek Group plc: Company Snapshot
Table 104. Intetek Group plc: Operating Segments
Table 105. Intetek Group plc: Product Portfolio
Table 106. Intetek Group plc: Net Sales
Table 107. Intetek Group plc: Key Stratergies
Table 108. Wuxi Apptec: Key Executives
Table 109. Wuxi Apptec: Company Snapshot
Table 110. Wuxi Apptec: Operating Segments
Table 111. Wuxi Apptec: Product Portfolio
Table 112. Wuxi Apptec: Net Sales
Table 113. Wuxi Apptec: Key Stratergies
Table 114. Charles River Laboratories International, Inc.: Key Executives
Table 115. Charles River Laboratories International, Inc.: Company Snapshot
Table 116. Charles River Laboratories International, Inc.: Operating Segments
Table 117. Charles River Laboratories International, Inc.: Product Portfolio
Table 118. Charles River Laboratories International, Inc.: Net Sales
Table 119. Charles River Laboratories International, Inc.: Key Stratergies
List of Figures
Figure 1. Segmentation of Medical Device Analytical Testing Outsourcing Market, 2021-2031
Figure 2. Medical Device Analytical Testing Outsourcing Market, 2021-2031
Figure 3. Top Investment Pockets, by Region
Figure 4. Porter Five-1
Figure 5. Porter Five-2
Figure 6. Porter Five-3
Figure 7. Porter Five-4
Figure 8. Porter Five-5
Figure 9. Medical Device Analytical Testing Outsourcing Market: Drivers, Restraints and Opportunities
Figure 10. Medical Device Analytical Testing Outsourcing Market, by Service, 2021 (%)
Figure 11. Comparative Share Analysis of Physical Testing Medical Device Analytical Testing Outsourcing Market, 2021 and 2031 (%)
Figure 12. Comparative Share Analysis of Bioburden Testing Medical Device Analytical Testing Outsourcing Market, 2021 and 2031 (%)
Figure 13. Comparative Share Analysis of Sterility Testing Medical Device Analytical Testing Outsourcing Market, 2021 and 2031 (%)
Figure 14. Comparative Share Analysis of Others Medical Device Analytical Testing Outsourcing Market, 2021 and 2031 (%)
Figure 15. Medical Device Analytical Testing Outsourcing Market, by End-user, 2021 (%)
Figure 16. Comparative Share Analysis of Medical Device Manufacturer Medical Device Analytical Testing Outsourcing Market, 2021 and 2031 (%)
Figure 17. Comparative Share Analysis of Pharmaceutical Companies Medical Device Analytical Testing Outsourcing Market, 2021 and 2031 (%)
Figure 18. Medical Device Analytical Testing Outsourcing Market by Region, 2021
Figure 19. U.S. Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 20. Canada Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 21. Mexico Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 22. Germany Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 23. France Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 24. UK Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 25. Italy Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 26. Spain Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 27. Rest of Europe Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 28. Japan Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 29. China Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 30. Australia Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 31. India Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 32. South Korea Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 33. Rest of Asia-Pacific Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 34. Brazil Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 35. Saudi Arabia Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 36. South Africa Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 37. Rest of LAMEA Medical Device Analytical Testing Outsourcing Market, 2021-2031 ($Million)
Figure 38. Top Winning Strategies, by Year
Figure 39. Top Winning Strategies, by Development
Figure 40. Top Winning Strategies, by Company
Figure 41. Product Mapping of Top 10 Players
Figure 42. Competitive Dashboard
Figure 43. Competitive Heatmap of Top 10 Key Players
Figure 44. Top Player Positioning, 2021
Figure 45. Sgs Sa.: Net Sales ($Million)
Figure 46. Medistri Sa.: Net Sales ($Million)
Figure 47. Element Materials Technology.: Net Sales ($Million)
Figure 48. Pace Analytical.: Net Sales ($Million)
Figure 49. North American Science Associates, LLC.: Net Sales ($Million)
Figure 50. The Smithers Group Inc..: Net Sales ($Million)
Figure 51. Eurofins Scientific.: Net Sales ($Million)
Figure 52. Intetek Group plc.: Net Sales ($Million)
Figure 53. Wuxi Apptec.: Net Sales ($Million)
Figure 54. Charles River Laboratories International, Inc..: Net Sales ($Million)
Executive Summary
According to the report titled, “Medical Device Analytical Testing Outsourcing Market," The medical device analytical testing outsourcing market was valued at $4,744.84 million in 2021 and is projected to reach $7,956.99 million by 2031, growing at a CAGR of 5.3% from 2022 to 2031.Medical device analytical testing outsourcing is a process for medical device manufacturers to check the quality of their products by contracting with other companies by conducting the testing. These analytical testing used for medical devices which includes physical testing, sterility testing, bioburden testing and others. Medical device analytical testing outsourcing refers to a specific type of contract between the manufacturer and the third-party companies for manufacturing, validation, packing, prototyping, designing, and verifying the medical devices in a sterile and controlled environment for supply chain management.
Key factors driving the growth of the medical device analytical testing outsourcing market include growing need for medical testing and validation for medical devices and rise in adoption of analytical testing services such as physical testing, sterility testing, and others. In addition, rise in adoption of the medical devices such as cardiovascular devices, orthopedic devices, dental implants have led to increase the demand for analytical testing services for medical devices and further supports the growth of market. Furthermore, rise in standards and regulations relating to services for medical device validation and verification stimulate the growth of the market. In addition, various initiatives by public organizations promoting the testing of medical devices drive the market growth.
Furthermore, Food Drug Administration (FDA) has regulated the guidelines, for ensuring the products quality, safety, and accuracy before its use. Hence, validation and medical testing is necessary for medical equipment which further contributes toward market growth. Moreover, presence of well-established healthcare systems and rise in healthcare expenditure boost the market growth. Thus, increase in the prevalence of cardiovascular disease among population, presence of well-established healthcare systems, and rise in R&D activities for cardiovascular disease led to increases the demand for outsourcing of cardiovascular devices which contributes towards market growth.
The market also offers growth opportunities to the key players in the market. Rise in affordability of healthcare infrastructure and surge in medical expenditure in developing countries such as China, Japan, India and rise in healthcare spending this has led to surge in demand for medical devices analytical testing services, thereby provides the lucrative opportunity to the market growth. In addition, strong presence of pharmaceutical manufacturers in the developed countries are expected to create a positive impact on the market growth. Furthermore, rise in health care expenditure significantly impacts growth of various pharmaceutical sectors in the healthcare industry. For instance, according to the Medicare and Medicaid Services, the National Health Expenditure (NHE) reached $3.8 trillion in 2019. The NHE increased by 4.6% in 2019 and accounted for 17.7% of the U.S. GDP. Thus, increase in healthcare spending, surge in demand for medical devices analytical testing, owing to increase in prevalence of chronic diseases are expected to provide remunerative opportunities for expansion of the global medical device analytical testing outsourcing market during the forecast period.
The medical device analytical testing outsourcing market is segmented into service, end user, and region. On the basis of service, the market is categorized into physical testing, bioburden testing, sterility testing, and others. On the basis of end user, it is categorized into medical device manufacturer and pharmaceutical companies. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players profiled in the study include Charles River Laboratories International, Inc., Element Materials Technology, Eurofins Scientific, Intetek Group plc, Pace Analytical, Medistri SA, North American Science Associates, LLC, SGS SA, The Smithers Group Inc., and WuXi AppTec. The players in the market have been actively engaged in the adoption of various strategies such as acquisition, approval and expansion to remain competitive and gain advantage over the competitors in the market. For instance, in March 2021, Smithers Group Inc, a provider of testing, consulting, information, and compliance services has opened the new physical and functional medical device testing laboratory in Akron, Ohio to expand its business portfolio.
Key Market Insights
- By service, the others segment was the highest revenue contributor to the market in 2021 and is estimated to reach $3,812.71 million by 2031, with a CAGR of 4.5%. However, the sterility testing segment is estimated to be the fastest-growing segment with a CAGR of 7.5% during the forecast period.
- By end user, the medical device manufacturer segment dominated the global market in 2021 and is expected to be the fastest-growing segment with a highest CAGR of 5.7% during the forecast period.
- Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period
Companies Mentioned
- SGS SA
- Medistri SA
- Element Materials Technology
- Pace Analytical
- North American Science Associates, LLC
- The Smithers Group Inc.
- Eurofins Scientific
- Intetek Group plc
- WuXi AppTec
- Charles River Laboratories International, Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
